Chris Siedem

research investigator at Array BioPharma Inc. - Boulder, CO, US

Chris Siedem's Contact Details
HQ
303-381-6600
Location
Company
Array BioPharma Inc.
Chris Siedem's Company Details
Array BioPharma Inc. logo, Array BioPharma Inc. contact details

Array BioPharma Inc.

Boulder, CO, US • 100 - 249 Employees
Major Drugs

Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.

oncology biotechnology melanoma colorectal cancer B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals
Details about Array BioPharma Inc.
Frequently Asked Questions about Chris Siedem
Chris Siedem currently works for Array BioPharma Inc.
Chris Siedem's role at Array BioPharma Inc is research investigator.
Chris Siedem's email address is ***@arraybiopharma.com. To view Chris Siedem's full email address, please signup to ConnectPlex.
Chris Siedem works in the Pharmaceuticals industry.
Chris Siedem's colleagues at Array BioPharma Inc. are Robert Kirk, Janice Messer, Kelly Garr, Molly Blasing, Emma Hendrickson, Mike Genova, Motria Horodysky and others.
Chris Siedem's phone number is 303-381-6600
See more information about Chris Siedem